Experience of the out-patient use of memotropil in the treatment of cognitive disorders in patients with chronic progressive cerebrovascular disorders

Neurosci Behav Physiol. 2009 Feb;39(2):193-7. doi: 10.1007/s11055-009-9109-7.

Authors

T T Batysheva¹, L V Bagir', E V Kostenko, I Yu Artemova, T V Vdovichenko, P A Ganzhula, E Yu Zhuravleva, A M Ismailov, L N Lisenker, O V Nesterova, O V Otcheskaya, L D Rotor, A A Khozova, A N Boiko

Affiliation

¹ Rehabilitation Clinic No. 7, Central Administrative District, Moscow, Russia.

PMID: 19140003
DOI: 10.1007/s11055-009-9109-7

No abstract available

MeSH terms

Aged
Ambulatory Care
Cerebrovascular Disorders / complications*
Chronic Disease
Cognition Disorders / etiology*
Disease Progression
Female
Humans
Male
Middle Aged
Neuroprotective Agents / therapeutic use*
Neuropsychological Tests
Piracetam / therapeutic use*
Severity of Illness Index

Substances

Neuroprotective Agents
Piracetam